Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating cadiovascular and orthopaedics diseases

An orthopedic surgery and cardiovascular technology, applied in the field of traditional Chinese medicine compositions, can solve problems such as toxic and side effects of chemicals, and achieve the effects of improving calcium pump activity, increasing cardiovascular and cerebral blood flow, and increasing cerebrovascular and coronary blood flow.

Inactive Publication Date: 2012-04-25
YUNNAN CHUXIONG TIANLI PHARMA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, although there are many kinds of medicines for treating this kind of diseases, the chemical medicines among them have the problem of toxic and side effects, and there are few traditional Chinese medicine preparations with good curative effects, especially Chinese medicines that have curative effects on cardiovascular diseases and orthopedic diseases. is rare

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug for treating cadiovascular and orthopaedics diseases
  • Drug for treating cadiovascular and orthopaedics diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] (1) Take materials according to the following mass parts:

[0038] Panax notoginseng saponins 50 parts

[0039] Purple salvia 400 parts

[0040] 225 parts of Erigeron lanceolata;

[0041](2) Pulverize the purple salvia miltiorrhiza and breviscapine in the step (1) into a coarse powder, and pulverize the total saponins of notoginseng in the step (1) into a fine powder; Add ethanol with a mass concentration of 95% to the coarse powder of Erigeron breviscapus for reflux extraction for 1.5 hours, then filter; then add ethanol with a mass concentration of 50% to the filter residue according to the solid-liquid mass ratio of 1:5 for reflux extraction for 1 hour , and then filter to obtain the filter residue; combine the filtrate extracted twice by reflux, and reclaim ethanol to obtain the ethanol extract;

[0042] (3) Decoct the filter residue obtained in step (2) with water for 2 hours at a solid-to-liquid mass ratio of 1:6, filter to obtain a decoction; then combine the ...

Embodiment 2

[0045] (1) Take materials according to the following mass parts:

[0046] Panax notoginseng saponins 30 parts

[0047] Purple salvia 450 parts

[0048] 200 parts of Erigeron lanceolata;

[0049] (2) Pulverize the purple salvia miltiorrhiza and breviscapine in the step (1) into a coarse powder, and pulverize the total saponins of notoginseng in the step (1) into a fine powder; Add ethanol with a mass concentration of 95% to the coarse powder of Erigeron breviscapus for reflux extraction for 2 hours, then filter; then add ethanol with a mass concentration of 50% to the filter residue at a solid-liquid mass ratio of 1:7 for reflux extraction for 0.5 hours , and then filter to obtain the filter residue; combine the filtrate extracted twice by reflux, and reclaim ethanol to obtain the ethanol extract;

[0050] (3) Decoct the filter residue obtained in step (2) according to the solid-to-liquid mass ratio of 1:4, add water for 3 hours, filter to obtain a decoction; then combine th...

Embodiment 3

[0052] (1) Take materials according to the following mass parts:

[0053] Panax notoginseng total saponins 80 parts

[0054] Purple salvia 350 parts

[0055] 250 parts of Erigeron lanceolata;

[0056] (2) Pulverize the purple salvia miltiorrhiza and breviscapine in the step (1) into a coarse powder, and pulverize the total saponins of notoginseng in the step (1) into a fine powder; Add ethanol with a mass concentration of 95% to the coarse powder of Erigeron breviscapus for reflux extraction for 1 hour, then filter; then add ethanol with a mass concentration of 50% to the filter residue at a solid-liquid mass ratio of 1:3 for reflux extraction for 1.5 hours , and then filter to obtain the filter residue; combine the filtrate extracted twice by reflux, and reclaim ethanol to obtain the ethanol extract;

[0057] (3) Decoct the filter residue obtained in step (2) with water for 1 hour at a solid-to-liquid mass ratio of 1:8, filter to obtain a decoction; then combine the ethano...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a drug Huoxuewang for treating cadiovascular and orthopaedics diseases. The components of the drug comprise, by mass, 30-80 parts of panax notoginsenosidum, 350-450 parts of radix salviae miltiorrhizae and 200-250 parts of shortscape fleabane herb. According to the present invention, ethanol is added to the radix salviae miltiorrhizae coarse powder and the shortscape fleabane herb coarse powder; a reflux extraction treatment is performed two times; the resulting filter residue is added with water, and is decocted; the resulting extracting solution by the ethanol is mixed with the resulting decoction solution by the water, and the resulting mixture is concentrated into condensed extract; the panax notoginsenosidum fine powder is added to the condensed extract to obtain the traditional Chinese drug composition with effects of blood activating and blood stasis dissipating. The traditional Chinese drug composition of the present invention has effectivenesses of blood activating and blood stasis dissipating, swelling subsiding and pain relieving, blood circulation promoting and collateral activating, and the like, and has effects of good pain relieving and inflammation eliminating, acceleration of healing of fracture and wound tissues. The traditional Chinese drug composition of the present invention provides good therapeutic effects for cadiovascular diseases, pectoral stuffiness pain caused by qi-stagnancy and blood stasis, and vertigo, wherein the pectoral stuffiness pain is angina pectoris of the coronary heart disease, the vertigo is cerebral arteriosclerosis. In addition, the traditional Chinese drug composition of the present invention has significant therapeutic effects of quick recovery, low recurrence rate, high safety, no side effects and the like, and the production of the traditional Chinese drug composition is simple.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to Huoxuewang, a medicine that has the effect of promoting blood circulation and removing blood stasis, and can simultaneously treat cardiovascular and orthopedic diseases, and belongs to the field of biotechnology. Background technique [0002] With the improvement of people's living standards in our country, the quality of life of residents is constantly improving. Many people's diet is not scientific, thinking that eating more fish and meat means improving the quality of life, but it is not the case. Middle-aged people over the age of 45, obese people, people with a family history of hyperlipidemia, people who often participate in eating, drinking and socializing, and workers with high mental stress are prone to cardiovascular diseases. Common symptoms include palpitations, syncope, dyspnea, dizziness, etc., which directly affect the health and quality of life of midd...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/537A61P9/00A61P9/10A61P19/02A61P19/08A61P29/00
Inventor 厉君
Owner YUNNAN CHUXIONG TIANLI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com